PCI Registry Basel
1 other identifier
observational
10,000
1 country
1
Brief Summary
This registry aims to learn more about the best ways to treat coronary artery disease. Information from routine medical care will be collected to compare different treatment approaches, including drug-eluting stents, drug-coated balloons (DCB), and bioresorbable scaffolds (BRS), which gradually dissolve over time. The registry will include people with coronary artery disease who receive an intervention (percutaneous coronary intervention), including those undergoing more complex procedures. By studying treatment outcomes over time, the Registry aims to better understand which therapies work best for different groups of patients and to improve future care for people with coronary artery disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 31, 2026
CompletedFirst Posted
Study publicly available on registry
September 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2035
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2035
September 10, 2026
September 1, 2026
10 years
August 31, 2026
September 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Target Vessel Failure (TVF)
Composite endpoint defined as the occurrence of cardiovascular death, target vessel myocardial infarction, or unplanned target vessel revascularisation.
Through study completion, an average of 1 year
Other Outcomes (8)
All-Cause Mortality
Through study completion, an average of 1 year
Cardiovascular Mortality
Through study completion, an average of 1 year
Occurrence of Myocardial Infarction
Through study completion, an average of 1 year
- +5 more other outcomes
Eligibility Criteria
The study population consits of patients undergoing percutaneous coronary interventions (PCI) at the University Hospital Basel
You may qualify if:
- Patients treated at the University Hospital Basel
- Undergoing complex PCI (e.g. left main, bifurcation, multivessel PCI, rotational atherectomy or other calcium modification, complex anatomy). The definition complex will be a clinical/ procedural/ anatomical definition made by the operator.
- Undergoing CTO or CHIP (Complex High-risk Indicated Patient) procedures
- Treated with a DCB strategy
- Treated with a BRS
You may not qualify if:
- Patients under 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregor Leibundgut, Prof. Dr. med.
University Hospital, Basel, Switzerland
- PRINCIPAL INVESTIGATOR
Jasper Boeddinghaus, PD Dr. med.
University Hospital, Basel, Switzerland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2026
First Posted
September 10, 2026
Study Start
October 1, 2025
Primary Completion (Estimated)
October 1, 2035
Study Completion (Estimated)
October 1, 2035
Last Updated
September 10, 2026
Record last verified: 2026-09